S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Range Cancer Therapeutics ETF (CNCR) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$219.82K
Number of
Institutional Sellers
(last 12 months)
0
Get CNCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Range Cancer Therapeutics ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CNCR Institutional Buying and Selling by Quarter

Range Cancer Therapeutics ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024OLD Mission Capital LLC16,319$220K0.0%N/A1.813%
2/10/2023CoreCap Advisors LLC3,107$43K0.0%N/A0.222%
11/15/2022Flow Traders U.S. LLC17,881$262K0.0%N/A1.277%
8/11/2022CoreCap Advisors LLC9,107$138K0.0%N/A0.651%
11/15/2021Flow Traders U.S. LLC10,762$327K0.0%-69.9%0.769%
11/10/2021Blue Bell Private Wealth Management LLC1,374$42K0.0%-26.7%0.098%
8/24/2021Flow Traders U.S. LLC35,759$1.14M0.1%N/A2.466%
4/23/2021Blue Bell Private Wealth Management LLC1,874$56K0.0%+30.7%0.129%
1/21/2021Blue Bell Private Wealth Management LLC1,434$50K0.0%-22.2%0.096%
(Data available from 1/1/2016 forward)

CNCR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CNCR shares?

During the previous two years, the following institutional investors and hedge funds held shares of Range Cancer Therapeutics ETF shares: Flow Traders U.S. LLC ($262K), and OLD Mission Capital LLC ($220K), CoreCap Advisors LLC ($43K).Learn more on CNCR's institutional investors.

Which institutional investors have been buying Range Cancer Therapeutics ETF stock?

The following institutional investors have purchased Range Cancer Therapeutics ETF stock in the last 24 months: Flow Traders U.S. LLC ($17.88K), OLD Mission Capital LLC ($16.32K), and CoreCap Advisors LLC ($12.21K).

How much institutional buying is happening at Range Cancer Therapeutics ETF?

Institutional investors have bought a total of 46,414 shares in the last 24 months. This purchase volume represents approximately $1.10M in transactions.


This page (NASDAQ:CNCR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners